Abstract

Relevance. Currently, the pathology of the joints in broiler chickens remains relevant, especially when the bird is actively growing and gaining weight. Despite the many antibacterial drugs, the results of treatment do not always give a positive effect. This may be due to the properties of the pathogens themselves, which have adapted to resist antibiotics, including the formation of biofilms, limited penetration of the drug into the site of infection, which leads to a decrease in the optimal concentration of the active substance at the site of the pathological process.Methodology. The production experiment was carried out at a poultry farm for the production of poultry meat with cage keeping of broiler chickens of the Соbb 500 cross. In the phase of active growth of broiler chickens, based on clinical, laboratory and histological studies of previous batches of growing broiler chickens, «Spelink®-660» was introduced into the treatment regimen for a new batch of poultry.Results. Production experience has shown that the consistent introduction of the drug with the active ingredient enrofloxacin, colistin sulfate and «Spelink®-660» into the treatment regimen for broiler chickens in the first decade of growing allowed to achieve the best zootechnical indicators and reduce the mortality of birds during the fattening period due to joint pathology.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.